3-Fluoromethcathinone
3-Fluoromethcathinone[edit]
3-Fluoromethcathinone, also known as 3-FMC, is a synthetic stimulant of the cathinone class. It is a fluorinated derivative of methcathinone, and it is structurally related to other synthetic cathinones such as mephedrone and 3-fluoromethamphetamine.
Chemical Structure and Properties[edit]
3-Fluoromethcathinone is characterized by the presence of a fluorine atom at the third position of the phenyl ring. This modification is believed to influence its pharmacological properties, including its potency and duration of action. The chemical formula for 3-FMC is C10H12FNO, and it has a molecular weight of 181.21 g/mol.
Pharmacology[edit]
3-FMC acts as a central nervous system stimulant. It is thought to exert its effects primarily by increasing the levels of neurotransmitters such as dopamine, norepinephrine, and serotonin in the brain. This is achieved through the inhibition of their reuptake into presynaptic neurons, similar to the mechanism of action of other cathinones.
Effects and Usage[edit]
The effects of 3-Fluoromethcathinone are similar to those of other stimulant drugs. Users may experience increased alertness, euphoria, enhanced sociability, and increased energy. However, the use of 3-FMC can also lead to adverse effects such as anxiety, paranoia, and cardiovascular issues.
Legal Status[edit]
The legal status of 3-Fluoromethcathinone varies by country. In many jurisdictions, it is classified as a controlled substance due to its potential for abuse and lack of accepted medical use. It is important for researchers and users to be aware of the legal implications of possessing or distributing this compound.
Safety and Toxicity[edit]
The safety profile of 3-FMC is not well-established, and its use is associated with potential health risks. As with other synthetic cathinones, there is a risk of overdose, which can lead to severe health complications or death. Users are advised to exercise caution and seek medical attention if adverse effects occur.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
